Business Description
West Pharmaceutical Services Inc
NAICS : 339112
SIC : 3841
ISIN : US9553061055
Description
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.96 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | 0.38 | |||||
| Interest Coverage | 79.18 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 20.66 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year EBITDA Growth Rate | 17.9 | |||||
| 3-Year EPS without NRI Growth Rate | 19.3 | |||||
| 3-Year FCF Growth Rate | 11.9 | |||||
| 3-Year Book Growth Rate | 16.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 6.87 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.21 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 0.01 | |||||
| 6-1 Month Momentum % | -8.8 | |||||
| 12-1 Month Momentum % | -8.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | |||||
| Quick Ratio | 1.95 | |||||
| Cash Ratio | 0.93 | |||||
| Days Inventory | 86.97 | |||||
| Days Sales Outstanding | 64.88 | |||||
| Days Payable | 45.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 5.8 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | 2.68 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.15 | |||||
| Operating Margin % | 22.71 | |||||
| Net Margin % | 19.42 | |||||
| FCF Margin % | 13.25 | |||||
| ROE % | 20.38 | |||||
| ROA % | 15.3 | |||||
| ROIC % | 21.53 | |||||
| ROC (Joel Greenblatt) % | 33.69 | |||||
| ROCE % | 21.55 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.61 | |||||
| Forward PE Ratio | 49.19 | |||||
| PE Ratio without NRI | 48.1 | |||||
| Shiller PE Ratio | 74.32 | |||||
| Price-to-Owner-Earnings | 56.11 | |||||
| PEG Ratio | 2.19 | |||||
| PS Ratio | 9.43 | |||||
| PB Ratio | 10.03 | |||||
| Price-to-Tangible-Book | 10.51 | |||||
| Price-to-Free-Cash-Flow | 71.62 | |||||
| Price-to-Operating-Cash-Flow | 36.51 | |||||
| EV-to-EBIT | 39.27 | |||||
| EV-to-Forward-EBIT | 38.43 | |||||
| EV-to-EBITDA | 32.48 | |||||
| EV-to-Forward-EBITDA | 31.54 | |||||
| EV-to-Revenue | 9.06 | |||||
| EV-to-Forward-Revenue | 8.94 | |||||
| EV-to-FCF | 68.75 | |||||
| Price-to-Projected-FCF | 4.06 | |||||
| Price-to-DCF (Earnings Based) | 1.54 | |||||
| Price-to-DCF (FCF Based) | 2.29 | |||||
| Price-to-Median-PS-Value | 1.79 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.3 | |||||
| Price-to-Graham-Number | 4.74 | |||||
| Price-to-Net-Current-Asset-Value | 34.89 | |||||
| Earnings Yield (Greenblatt) % | 2.55 | |||||
| FCF Yield % | 1.44 | |||||
| Forward Rate of Return (Yacktman) % | 21.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
West Pharmaceutical Services Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 50,177.495 | ||
| EPS (TTM) (MXN) | 130.007 | ||
| Beta | 0 | ||
| Volatility % | 11.13 | ||
| 14-Day RSI | 0.01 | ||
| 14-Day ATR (MXN) | 0.216037 | ||
| 20-Day SMA (MXN) | 6043.95 | ||
| 12-1 Month Momentum % | -8.56 | ||
| 52-Week Range (MXN) | 6043.95 - 6682.31 | ||
| Shares Outstanding (Mil) | 72.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
West Pharmaceutical Services Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
West Pharmaceutical Services Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
West Pharmaceutical Services Inc Frequently Asked Questions
What is West Pharmaceutical Services Inc(MEX:WST)'s stock price today?
The current price of MEX:WST is MXN6043.95. The 52 week high of MEX:WST is MXN6682.31 and 52 week low is MXN6043.95.
When is next earnings date of West Pharmaceutical Services Inc(MEX:WST)?
The next earnings date of West Pharmaceutical Services Inc(MEX:WST) is 2024-07-26 Est..
Does West Pharmaceutical Services Inc(MEX:WST) pay dividends? If so, how much?
West Pharmaceutical Services Inc(MEX:WST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers